Clinuvel Pharmaceuticals
CUV.AX
#8536
Rank
ยฃ0.21 B
Marketcap
ยฃ4.18
Share price
-0.25%
Change (1 day)
-29.60%
Change (1 year)

Revenue for Clinuvel Pharmaceuticals (CUV.AX)

Revenue in 2026: ยฃ49.13 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ49.13 Million. In 2026 the company made a revenue of ยฃ49.13 Million an increase over the revenue in the year 2025 that were of ยฃ47.25 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Clinuvel Pharmaceuticals from 2001 to 2026

Annual revenue

Year Revenue Change
2026ยฃ49.13 M3.99%
2025ยฃ47.25 M6.21%
2024ยฃ44.48 M12.75%
2023ยฃ39.45 M15.14%
2022ยฃ34.27 M26.03%
2021ยฃ27.19 M60.04%
2020ยฃ16.99 M3.08%
2019ยฃ16.48 M15.58%
2018ยฃ14.26 M46.97%
2017ยฃ9.7 M177.46%
2016ยฃ3.49 M106.53%
2015ยฃ1.69 M7.98%
2014ยฃ1.56 M46.33%
2013ยฃ1.07 M91.51%
2012ยฃ0.55 M-33.65%
2011ยฃ0.84 M
2010N/A
2009N/A
2008N/A-100%
2007ยฃ0.18 M-57.04%
2006ยฃ0.42 M487.15%
2005ยฃ0.07 M
2004N/A
2002N/A
2001N/A